THALIDOMIDE IN THE TREATMENT OF WOMEN WITH CHRONIC PELVIC PAIN/ENDOMETRIOSIS

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究将观察沙利度胺治疗是否能减少标准治疗不成功的女性盆腔炎患者的慢性盆腔疼痛。该研究还将观察沙利度胺治疗是否会降低血液中TNF-α和IL-6的水平。子宫内膜异位症患者体内这些化学物质的水平通常高于平均水平，并且可能导致慢性盆腔疼痛。最后，该研究将观察参与者的整体生活质量和功能是否在接受沙利度胺治疗时得到改善。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This research study will see if treatment with thalidomide reduces chronic pelvic pain in women with endometriosisi who have not been successful with standard treatment. The study will also be looking to see if thalidomide treatment lowers the levels of TNF-alpha and IL-6 in the blood. The levels of these chemicals in women with endometriosis are often higher than average and my contribute to chronic pelvic pain. Finally, the study will see if the participants' overall quality of life and functionality is improved while being treated with thalidomide.